Kinesin family member 20B regulates tongue cancer progression by promoting cell proliferation

Li,Zhang‑Yi; Wang,Zhi‑Xing; Li,Chang‑Chun

doi:10.3892/mmr.2019.9851

Kinesin family member 20B regulates tongue cancer progression by promoting cell proliferation

Authors:
- Zhang‑Yi Li
- Zhi‑Xing Wang
- Chang‑Chun Li
View Affiliations

Affiliations: Department of Stomatology, The Fifth Central Hospital of Tianjin, Tianjin Medical University, Tanggu, Tianjin 300450, P.R. China
Published online on: January 11, 2019 https://doi.org/10.3892/mmr.2019.9851
Pages: 2202-2210
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oral cancer refers to the malignant tumors that occur in the oral cavity, of which 80% are squamous cell carcinomas. The incidence of oral cancer accounts for ~5% of the incidence of systemic malignancies, with rapid progression, extensive infiltration and poor prognosis. In the present study, Kinesin family member (KIF)20B, a member of Kinesin‑6 family, was identified as a potential biomarker which could promote cancer progression. A total of 82 patients were recruited and KIF20B expression levels were investigated by immunohistochemistry, and were divided into high and low groups based on the median of KIF20B expression levels. The clinicopathological features and survival‑associated data of the two groups were analyzed and the results were provided as a table and by a Kaplan‑Meier plot, respectively. Additionally, KIF20B was successfully silenced in two tongue cancer cell lines, CAL‑27 and TCA‑8113. MTT and colony formation assay were performed to determine the changes of cell proliferation in knocked down‑KIF20B cell lines. In addition, proliferation‑associated proteins Ki67 and PCNA were investigated, by western blotting. In animal experiments, subcutaneous tumor formation was performed with control cells and cells with knocked down KIF20B, to determine the inhibitory effect of KIF20B in vivo. Firstly, it was found that there was significantly high expression levels of KIF20B in tongue cancer patients (P<0.05). Patients with high expression of KIF20B had poorer clinicopathological results including tumor differentiation level, lymph node metastasis and clinical stages. The overall survival and relapse‑free survival of high‑expression group were also poor. Secondly, after successful establishment of cells with knocked down KIF20B, this resulted in a notable reduction in cell proliferation in vitro. Subsequent western blotting further confirmed that Ki67 and PCNA expression levels had a significant decline. Finally, it was demonstrated that knocking down KIF20B could inhibit tumor volume growth in vivo. In conclusion, the high level of KIF20B in oral squamous cell carcinoma was significantly associated with poor clinicopathological features and survival. KIF20B might promote cancer development through enhancing cell proliferation in vitro, and might be a potential biomarker of oral squamous cell carcinoma.

View Figures

View References

1	Lingen MW, Kalmar JR, Karrison T and Speight PM: Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 44:10–22. 2008. View Article : Google Scholar : PubMed/NCBI
2	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
3	Matsumoto-Taniura N, Pirollet F, Monroe R, Gerace L and Westendorf JM: Identification of novel M phase phosphoproteins by expression cloning. Mol Biol Cell. 7:1455–1469. 1996. View Article : Google Scholar : PubMed/NCBI
4	Kanehira M, Katagiri T, Shimo A, Takata R, Shuin T, Miki T, Fujioka T and Nakamura Y: Oncogenic role of MPHOSPH1, a cancer-testis antigen specific to human bladder cancer. Cancer Res. 67:3276–3285. 2007. View Article : Google Scholar : PubMed/NCBI
5	Abaza A, Soleilhac JM, Westendorf J, Piel M, Crevel I, Roux A and Pirollet F: M phase phosphoprotein 1 is a human plus-end-directed kinesin-related protein required for cytokinesis. J Biol Chem. 278:27844–27852. 2003. View Article : Google Scholar : PubMed/NCBI
6	Obara W, Ohsawa R, Kanehira M, Takata R, Tsunoda T, Yoshida K, Takeda K, Katagiri T, Nakamura Y and Fujioka T: Cancer peptide vaccine therapy developed from oncoantigens identified through genome-wide expression profile analysis for bladder cancer. Jpn J Clin Oncol. 42:591–600. 2012. View Article : Google Scholar : PubMed/NCBI
7	Liu X, Zhou Y, Liu X, Peng A, Gong H, Huang L, Ji K, Petersen RB, Zheng L and Huang K: MPHOSPH1: A potential therapeutic target for hepatocellular carcinoma. Cancer Res. 74:6623–6634. 2014. View Article : Google Scholar : PubMed/NCBI
8	Lin WF, Lin XL, Fu SW, Yang L, Tang CT, Gao YJ, Chen HY and Ge ZZ: Pseudopod-associated protein KIF20B promotes Gli1-induced epithelial-mesenchymal transition modulated by pseudopodial actin dynamic in human colorectal cancer. Mol Carcinog. 57:911–925. 2018. View Article : Google Scholar : PubMed/NCBI
9	Ansari D, Andersson R, Bauden MP, Andersson B, Connolly JB, Welinder C, Sasor A and Marko-Varga G: Protein deep sequencing applied to biobank samples from patients with pancreatic cancer. J Cancer Res Clin Oncol. 141:369–380. 2015. View Article : Google Scholar : PubMed/NCBI
10	Liu X, Li Y, Zhang X, Liu XY, Peng A, Chen Y, Meng L, Chen H, Zhang Y, Miao X, et al: Inhibition of kinesin family member 20B sensitizes hepatocellular carcinoma cell to microtubule-targeting agents by blocking cytokinesis. Cancer Sci. 109:3450–3460. 2018. View Article : Google Scholar : PubMed/NCBI
11	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
12	Miki H, Okada Y and Hirokawa N: Analysis of the kinesin superfamily: Insights into structure and function. Trends Cell Biol. 15:467–476. 2005. View Article : Google Scholar : PubMed/NCBI
13	Schlisio S, Kenchappa RS, Vredeveld LC, George RE, Stewart R, Greulich H, Shahriari K, Nguyen NV, Pigny P, Dahia PL, et al: The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev. 22:884–893. 2008. View Article : Google Scholar : PubMed/NCBI
14	Hirokawa N: Organelle transport along microtubules-the role of KIFs. Trends Cell Biol. 6:135–141. 1996. View Article : Google Scholar : PubMed/NCBI
15	Hirokawa N: Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science. 279:519–526. 1998. View Article : Google Scholar : PubMed/NCBI
16	Hirokawa N and Takemura R: Molecular motors and mechanisms of directional transport in neurons. Nat Rev Neurosci. 6:201–214. 2005. View Article : Google Scholar : PubMed/NCBI
17	Tipton AR, Wren JD, Daum JR, Siefert JC and Gorbsky GJ: GTSE1 regulates spindle microtubule dynamics to control Aurora B kinase and Kif4A chromokinesin on chromosome arms. J Cell Biol. 216:3117–3132. 2017. View Article : Google Scholar : PubMed/NCBI
18	Li QR, Yan XM, Guo L, Li J and Zang Y: AMPK regulates anaphase central spindle length by phosphorylation of KIF4A. J Mol Cell Biol. 10:2–17. 2018. View Article : Google Scholar : PubMed/NCBI
19	Gu Y, Lu L, Wu L, Chen H, Zhu W and He Y: Identification of prognostic genes in kidney renal clear cell carcinoma by RNAseq data analysis. Mol Med Rep. 15:1661–1667. 2017. View Article : Google Scholar : PubMed/NCBI
20	Hu CK, Coughlin M, Field CM and Mitchison TJ: KIF4 regulates midzone length during cytokinesis. Curr Biol. 21:815–824. 2011. View Article : Google Scholar : PubMed/NCBI
21	Lee YM, Lee S, Lee E, Shin H, Hahn H, Choi W and Kim W: Human kinesin superfamily member 4 is dominantly localized in the nuclear matrix and is associated with chromosomes during mitosis. Biochem J. 360:549–556. 2001. View Article : Google Scholar : PubMed/NCBI
22	Wu G and Chen PL: Structural requirements of chromokinesin Kif4A for its proper function in mitosis. Biochem Biophys Res Commun. 372:454–458. 2008. View Article : Google Scholar : PubMed/NCBI
23	Wandke C, Barisic M, Sigl R, Rauch V, Wolf F, Amaro AC, Tan CH, Pereira AJ, Kutay U, Maiato H, et al: Human chromokinesins promote chromosome congression and spindle microtubule dynamics during mitosis. J Cell Biol. 198:847–863. 2012. View Article : Google Scholar : PubMed/NCBI
24	Adams RR, Tavares AA, Salzberg A, Bellen HJ and Glover DM: Pavarotti encodes a kinesin-like protein required to organize the central spindle and contractile ring for cytokinesis. Genes Dev. 12:1483–1494. 1998. View Article : Google Scholar : PubMed/NCBI
25	Hill E, Clarke M and Barr FA: The Rab6-binding kinesin, Rab6-KIFL, is required for cytokinesis. EMBO J. 19:5711–5719. 2000. View Article : Google Scholar : PubMed/NCBI
26	Nislow C, Lombillo VA, Kuriyama R and McIntosh JR: A plus-end-directed motor enzyme that moves antiparallel microtubules in vitro localizes to the interzone of mitotic spindles. Nature. 359:543–547. 1992. View Article : Google Scholar : PubMed/NCBI
27	Janisch KM, McNeely KC, Dardick JM, Lim SH and Dwyer ND: Kinesin-6 KIF20B is required for efficient cytokinetic furrowing and timely abscission in human cells. Mol Biol Cell. 29:166–179. 2018. View Article : Google Scholar : PubMed/NCBI
28	Lucanus AJ and Yip GW: Kinesin superfamily: Roles in breast cancer, patient prognosis and therapeutics. Oncogene. 37:833–838. 2018. View Article : Google Scholar : PubMed/NCBI
29	Taniuchi K, Furihata M and Saibara T: KIF20A-mediated RNA granule transport system promotes the invasiveness of pancreatic cancercells. Neoplasia. 16:1082–1093. 2014. View Article : Google Scholar : PubMed/NCBI
30	Stangel D, Erkan M, Buchholz M, Gress T, Michalski C, Raulefs S, Friess H and Kleeff J: Kif20a inhibition reduces migration and invasion of pancreatic cancer cells. J Surg Res. 197:91–100. 2015. View Article : Google Scholar : PubMed/NCBI
31	Taniuchi K, Nakagawa H, Nakamura T, Eguchi H, Ohigashi H, Ishikawa O, Katagiri T and Nakamura Y: Down-regulation of RAB6KIFL/KIF20A, a kinesin involved with membrane trafficking of discs large homologue 5, can attenuate growth of pancreatic cancer cell. Cancer Res. 65:105–112. 2005.PubMed/NCBI
32	Asahara S, Takeda K, Yamao K, Maguchi H and Yamaue H: Phase I/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancer. J Transl Med. 11:2912013. View Article : Google Scholar : PubMed/NCBI
33	Yan GR, Zou FY, Dang BL, Zhang Y, Yu G, Liu X and He QY: Genistein-induced mitotic arrest of gastric cancer cells by downregulating KIF20A, a proteomics study. Proteomics. 12:2391–2399. 2012. View Article : Google Scholar : PubMed/NCBI
34	Khongkow P, Gomes AR, Gong C, Man EP, Tsang JW, Zhao F, Monteiro LJ, Coombes RC, Medema RH, Khoo US and Lam EW: Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance. Oncogene. 35:990–1002. 2016. View Article : Google Scholar : PubMed/NCBI
35	Sun X, Jin Z, Song X, Wang J, Li Y, Qian X, zhang Y and Yin Y: Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma. BMC Cancer. 15:9612015. View Article : Google Scholar : PubMed/NCBI
36	Kato T, Wada H, Patel P, Hu HP, Lee D, Ujiie H, Hirohashi K, Nakajima T, Sato M, Kaji M, et al: Overexpression of KIF23 predicts clinical outcome in primary lung cancer patients. Lung Cancer. 92:53–61. 2016. View Article : Google Scholar : PubMed/NCBI
37	Takahashi S, Fusaki N, Ohta S, Iwahori Y, Iizuka Y, Inagawa K, Kawakami Y, Yoshida K and Toda M: Downregulation of KIF23 suppresses glioma proliferation. J Neurooncol. 106:519–529. 2012. View Article : Google Scholar : PubMed/NCBI
38	Sun L, Zhang C, Yang Z, Wu Y, Wang H, Bao Z and Jiang T: KIF23 is an independent prognostic biomarker in glioma, transcriptionally regulated by TCF-4. Oncotarget. 7:24646–24655. 2016.PubMed/NCBI